Free SAS Institute A00-282 Exam Questions
Try our Free Demo Practice Tests for Comprehensive A00-282 Exam Preparation
-
SAS Institute A00-282 Exam Questions
-
Provided By: SAS Institute
- Exam: Clinical Trials Programming Using SAS 9.4
- Certification: SAS Programming Fundamentals
-
Total Questions: 145
-
Updated On: Jun 05, 2025
-
Rated: 4.9 |
-
Online Users: 290
-
Question 1
-
Which key organization is responsible for oversight and approval of clinical trials in the United States, ensuring that they are conducted according to regulatory requirements to safeguard participant health and collect reliable data?
Answer: B
-
Which key organization is responsible for oversight and approval of clinical trials in the United States, ensuring that they are conducted according to regulatory requirements to safeguard participant health and collect reliable data?
-
Question 2
-
A pharmaceutical company is preparing submission materials for a new drug application. One of the key documents required by regulatory authorities is define.xml. Which of the following best describes the purpose of the define.xml file?
Answer: B
-
A pharmaceutical company is preparing submission materials for a new drug application. One of the key documents required by regulatory authorities is define.xml. Which of the following best describes the purpose of the define.xml file?
-
Question 3
-
When implementing define.xml as part of a clinical trial study data submission package, which section is pivotal for explaining algorithmic derivations and handling of special data scenarios to a regulatory reviewer?
Answer: C
-
When implementing define.xml as part of a clinical trial study data submission package, which section is pivotal for explaining algorithmic derivations and handling of special data scenarios to a regulatory reviewer?
-
Question 4
-
During a clinical trial, data were collected on a nominal categorical variable indicating patients' blood type (Type A, Type B, Type AB, Type O). The goal is to analyze the distribution of blood types among patients who experienced an adverse event versus those who did not. Which of the following statistical methods BEST suits the objective of comparing the distribution of a nominal categorical variable across two independent groups?
Answer: D
-
During a clinical trial, data were collected on a nominal categorical variable indicating patients' blood type (Type A, Type B, Type AB, Type O). The goal is to analyze the distribution of blood types among patients who experienced an adverse event versus those who did not. Which of the following statistical methods BEST suits the objective of comparing the distribution of a nominal categorical variable across two independent groups?
-
Question 5
-
A clinical trial analyst needs to create a Kaplan-Meier survival plot to visualize the time-to-event data for different treatment groups. Which PROC step should the analyst use, and what is the key statement to differentiate the treatment groups in the graph?
Answer: B
-
A clinical trial analyst needs to create a Kaplan-Meier survival plot to visualize the time-to-event data for different treatment groups. Which PROC step should the analyst use, and what is the key statement to differentiate the treatment groups in the graph?